Industry committee  My understanding is there's only been the one notification.

Industry committee  And it was fulfilled.

Industry committee  It's our understanding they are going directly, with the assistance of one of the international organizations, to get the medicines in other ways, when they can and when they have the infrastructure and the other mechanisms to do so themselves.

Industry committee  The evidence we have that it wouldn't change is based on what we see and what we experience in the developing world.

Industry committee  Right, but we have to stop to see what.... It could potentially be used for far more than sending drugs to the developing world; it could be used in a broad number of ways.

Industry committee  Not Apotex—no, of course not—but almost anyone can use this regime if it is broadened. It wouldn't necessarily have to be Apotex that would use it. Why Apotex says it would use it more is I think really a question to ask Apotex.

Industry committee  Right. So it's not going to make a difference in the developing world—that is the point we're trying to make—because there are other reasons why medicines aren't going to get there. Why Apotex says it would make a difference is not clear to me.

Industry committee  I'm just concerned that it could be the case. I'm not pointing the finger at any particular company or saying that it would be the case.

Industry committee  We would say that CAMR is not the solution to the terrible problems the grandmothers have pointed out, and even if these changes were made to CAMR, they wouldn't result in an increased shipment of these medicines.

Industry committee  No, we don't believe it would make a difference, for the reasons we've explained.

Industry committee  A number of other countries besides Canada have access to medicines regimes: countries of the European Union, including the Netherlands, as well as Switzerland, Norway, India, Hong Kong, Korea, Singapore, and the Philippines. They all differ in many ways. Perhaps it would be mo

Industry committee  Canada is the only country of the ones I listed that has actually successfully seen medicines shipped using the regime. There are no other examples.

Industry committee  I can tell you a little bit about that, although I think the best people to answer the question would be the companies that were involved in the negotiation. There were, I gather, some lengthy negotiations, though they were not required under CAMR. So at the time they didn't rela

Industry committee  I believe that in this case there was a subsidy by the Clinton Foundation of the product that was being produced by Apotex, which made it cost effective.

Industry committee  I think the answer is really the answer that my colleagues from CIDA have been giving. It's really to participate in and contribute to a number of high-priority initiatives that Canada participates in--